top of page
  • Writer's pictureKelly Alica Liman

Top 49 VC Funds and Angel Investors in Switzerland

Despite its smaller population, Switzerland is especially entrepreneurial, having more startups per capita than neighboring countries. Switzerland's proclivity towards innovation has led to the success of its startup ecosystem, having produced more unicorns per capita than other countries in Europe. Known for its liberal economic system and educated populace that is responsive towards innovation, Switzerland has been able to maintain its reputation as an inventive country while remaining competitive in a developing sector; attracting an influx of funds and investments. In this article, we have compiled a comprehensive list of VC funds and angel investors in Switzerland that can assist you in your startup journey.


➡️ Click on the link to download ​the FULL LIST of VCs & Angel Investors including over 1,000+ listings with contact links!



VCs and Angel investors in Switzerland
VCs and Angel investors in Switzerland

Topics Covered:


 


Here are some reasons why you should consider raising funds for your startup in Switzerland:


  1. Access to capital: Sweden has a robust venture capital market, with Swiss entrepreneurs attracting record amounts of capital. In 2021, the venture capital poured into Swedish startups totaled USD 3.1 billion; with Switzerland's overall startup ecosystem now valued at USD 149 billion, over a threefold increase since 2016.

  2. Access to talent: Sweden has a highly competent and educated workforce, consistently ranking first in the world for talent competitiveness, according to the World Economic Forum. Switzerland's labor laws are notable for their liberal legislation and social stability, including an efficient healthcare framework, fantastic infrastructure, good living standards, and a simple tax system. These perks draw in professionals from all around the world while still retaining native talent.

  3. Innovative environment: Sweden has a strong culture of innovation, topping the charts of the Global Innovation Index for the 12th year in a row. It leads the world in terms of innovation outputs, particularly patents by origin, software spending, high-tech manufacturing and production, and export complexity. This is due to the high capacity of prominent research institutes to efficiently turn research discoveries into commercial goods. Through research and development, Swiss multinational organizations and other businesses also enhance their products, services, and processes.






The venture capitalist funds below are actively looking for investments in promising companies throughout various stages and sectors. The stages stated do not limit the possibility of getting funding if your company is at any stage other than what is listed.



  • Year of Inception: 2018

  • Stage: Pre Seed, Seed

  • Focus: Sector Agnostic

  • Notable Portfolio: Kickbite, Faircado, Aepsy, Peers, Amplo



  • Year of Inception: 2017

  • Stage: Pre Seed, Seed

  • Focus: Technology

  • Notable Portfolio: Ava, Wingtra, Kollabo, Ava Co



  • Year of Inception: 2020

  • Stage: Pre Seed, Seed

  • Focus: Web 3.0

  • Notable Portfolio: Grape, Liquity, Pods, Tempus, Myos



  • Year of Inception: 2020

  • Stage: Pre Seed, Seed, Series A

  • Focus: FinTech

  • Notable Portfolio: Lano, Monite, Pngme, Plend



  • Year of Inception: 2019

  • Stage: Pre Seed, Seed, Series A, Series B

  • Focus: Sector Agnostic

  • Notable Portfolio: Capskin, Beaconsmind, Growcer, PatchXR





  • Year of Inception: 2010

  • Stage: Pre Seed, Seed, Series A, Series B, Series C

  • Focus: Financial Services

  • Notable Portfolio: Artivest, Betterment, Bento, Hokodo, EasyHealth



  • Year of Inception: 2012

  • Stage: Seed

  • Focus: FinTech, Internet, Technology

  • Notable Portfolio: Dimoco, Fumbi, Gemini Interactive, Energyweb



  • Year of Inception: 2007

  • Stage: Seed, Series A

  • Focus: ICT, HealthTech

  • Notable Portfolio: Carvolution, N26, Razor Group, Lunaphore Technologies



  • Year of Inception: 2018

  • Stage: Seed, Series A

  • Focus: Blockchain

  • Notable Portfolio: DoxyChain, Forward, Sprinter, Orvium



  • Year of Inception: 2015

  • Stage: Seed, Series A

  • Focus: Fintech & Insurtech, Proptech, Healthtech, E-commerce

  • Notable Portfolio: Taurus, Yamo, Advanced Oncotherapy, Ava





  • Year of Inception: 2003

  • Stage: Seed, Series A

  • Focus: Biotechnology

  • Notable Portfolio: Cardior, Precirix, Scenic Biotech, Allecra Therapeutics


  • Year of Inception: 1993

  • Stage: Seed, Series A

  • Focus: Deep Tech, Life Sciences, Digital, High Tech

  • Notable Portfolio: Core Sensing, Avelo, Invasight, Tubulis



  • Year of Inception: 2016

  • Stage: Seed, Series A

  • Focus: Deep Tech, Fertility, Marketplace, Medtech, Software, Wearables

  • Notable Portfolio: Keyless, Deliveroo, Creoptix, Ava


  • Year of Inception: 2018

  • Stage: Seed, Series A

  • Focus: Blockchain, Web 3.0

  • Notable Portfolio: Keyless, Coinfirm, Peddler, Trovio, Delta Exchange



  • Year of Inception: 2020

  • Stage: Seed, Series A

  • Focus: Technology

  • Notable Portfolio: Cellestia, iQRON





  • Year of Inception: 2019

  • Stage: Seed, Series A

  • Focus: Climate Tech, Sustainable Agri & Food Tech, Clean Energy & Power, Green Transportation & Mobility, Advanced Manufacturing & Resource Efficiency, Carbon Capture, Storage & Utilization

  • Notable Portfolio: Pipe Predict, Blue Farm, e-mobilio, Flecto



  • Year of Inception: 2001

  • Stage: Seed, Series A

  • Focus: Therapeutics, Drug Development, Biotechnology

  • Notable Portfolio: Acrivon Therapeutics, BaseLaunch, MinervaX, eyevensys



Momenta Ventures

  • Year of Inception: 2015

  • Stage: Seed, Series A, Series B

  • Focus: Digital Industry, Deep Tech

  • Notable Portfolio: Decision Engines, Expeto, Eigen Innovations, Conservation Labs



  • Year of Inception: 2010

  • Stage: Seed, Series A, Series B

  • Focus: Science and Technology

  • Notable Portfolio: Code Intelligence, TheraPixel, Beekeeper, Byrd



  • Year of Inception: 2012

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Technology

  • Notable Portfolio: Eigen Technologies, Builder.ai, Sennder, Spotify, Revolut





  • Year of Inception: 2016

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Sustainable Food System, Biology, Technology, Agriculture

  • Notable Portfolio: Alpha Foods, Planted, Mosa Meat, Geltor, Tagger



  • Year of Inception: 2005

  • Stage: Seed, Series A, Series B, Series C

  • Focus: E-Commerce & Consumer Tech, Enterprise Tech, Media & Marketing, FinTech, InsurTech & PropTech, HealthTech

  • Notable Portfolio: Eureka, Exasol, Lunio, Rebuy, Biogate



  • Year of Inception: 1996

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Technology

  • Notable Portfolio: Figma, Revolut, Notion, Datadog, Farfetch, Discord



  • Year of Inception: 2016

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Life Sciences

  • Notable Portfolio: Abivax, Genmab, Levicept, Novocure, Molecular Partners








  • Year of Inception: 2000

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Digital Tech, Industrial Tech

  • Notable Portfolio: Ledgy, SumUp, DeepL, Raisin, Altoida



  • Year of Inception: 2003

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Technology, Healthcare

  • Notable Portfolio: Allthings, Blueprint Genetics, Wunderflats, Phenex Pharmaceuticals



  • Year of Inception: 2001

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Technology, Healthcare

  • Notable Portfolio: Acodis, Inositec, Ledgt, Nexthink, Picterra



  • Year of Inception: 2016

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Deep Tech, Fintech, Health, Mobility, Enterprise Software, Social Media, Cybersecurity

  • Notable Portfolio: Beekeeper, Lunaphore Technologies, Resistell, Lend



  • Year of Inception: 2000

  • Stage: Seed, Series A, Series B, Series C

  • Focus: HealthTech, Medical Devices, Diagnostics, Digital Health

  • Notable Portfolio: Relievant Medystems, Miach Orthopaedics, Virtual Incision, Kenbi





  • Year of Inception: 2001

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Healthcare

  • Notable Portfolio: Acrivon Therapeutics, Egenesis, Mineralys, Neurelis



  • Year of Inception: 2018

  • Stage: Seed, Series A, Series B, Series C

  • Focus: B2B, HealthTech, Medical Devices, Diagnostics, Digital Health

  • Notable Portfolio: Neurocare, InterAx, Gedea Biotech, Neotiv



  • Year of Inception: 2015

  • Stage: Seed, Series A, Series B, Series C

  • Focus: B2B, Software, Cyber Security, Big Data, Artificial Intelligence, Health Tech

  • Notable Portfolio: Via, Techsee, Nozomi Networks, Tribe Dynamics



  • Year of Inception: 1998

  • Stage: Series A

  • Focus: Biotechnology, Cancer Therapeutics, Oncology Therapeutics

  • Notable Portfolio: Arvinas, Turning Point Therapeutics, Blueprint Medicines, EQ Rx



  • Year of Inception: 2010

  • Stage: Series A

  • Focus: Circular Production & Consumption, Clean Energy, Sustainable Food

  • Notable Portfolio: Amandera, Beyond Impact, Farmstand, Ynsect





  • Year of Inception: 2016

  • Stage: Series A, Series B

  • Focus: Sector Agnostic

  • Notable Portfolio: CNC24, Calingo, Sinpex, RightNow, Xorlab



  • Year of Inception: 1991

  • Stage: Series A, Series B, Series C

  • Focus: Life Sciences, Therapeutics, Medical Devices, Diagnostics, Digital Health, Biotechnology

  • Notable Portfolio: Invendo Medical, STipe Therapeutics, MTM Laboratories, Amboss



  • Year of Inception: 2018

  • Stage: Series A, Series B, Series C

  • Focus: Artificial Intelligence, Machine Learning, Big Data, IoT, Automation, Immersive Technologies

  • Notable Portfolio: Tinamu Labs, Imverse, Astrocast, Smeetz



  • Year of Inception: 2000

  • Stage: Series A, Series B, Series C

  • Focus: Technology, Advanced Materials, Agriculture, Energy, Industrial IT, Water

  • Notable Portfolio: Aganova, Nanograf, Evergreen Solar, Optimatics, Energya Wind Technologies





  • Year of Inception: 1996

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Healthcare, Biotechnology

  • Notable Portfolio: Fore, GentiBio, Immunitas Therapeutics, Oculis



  • Year of Inception: 2007

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Technology

  • Notable Portfolio: Cato Networks, Billogram, SecuriThings, XFarm Technologies



  • Year of Inception: 2009

  • Stage: Seed, Series A, Series B, Series C

  • Focus: Agriculture & Food

  • Notable Portfolio: Sound Agriculture, Bionogsys, Agrofy, BlueNalu, MycoTechnology



  • Year of Inception: 2002

  • Stage: Series A, Series B, Series C

  • Focus: Life Sciences, Pharmaceuticals, Diagnostics, Digital Health

  • Notable Portfolio: Blueprint Medicines, Corvus, Enliven Therapeutics, Lumos Pharma





Angel Investors in Switzerland


The Angel investors listed below are part of an Angel community located throughout Switzerland. They may act as an individual or as a syndicate to fund projects of their preference, so these networks are the best opportunity for you to find a potential Angel with an aligned vision and interests.


  • Stage: Seed

  • Focus: Sector Agnostic

  • Notable Portfolio: -



  • Stage: Seed, Series A

  • Focus: Sector Agnostic

  • Notable Portfolio: Piavita, Goodwall, Avionic, Alao



  • Stage: Seed, Series A

  • Focus: Sector Agnostic

  • Notable Portfolio: -



  • Stage: Seed, Series A

  • Focus: Sector Agnostic

  • Notable Portfolio: Creoptix, Hylomorph, ActLight, Typewise, BC Platforms



  • Stage: Seed, Series A

  • Focus: Technology

  • Notable Portfolio: Adjoint, Advanon, Voltiris, Carbon Delta, Codecheck



  • Stage: Seed, Series A

  • Focus: e-Commerce, High Tech, MedTech, Automotive

  • Notable Portfolio: Clevver, Myos, Libify, Ubiq, Yeay



  • Stage: Seed, Series A

  • Focus: Healthcare

  • Notable Portfolio: Cellestia, Artidis, Elthera






Switzerland's startup environment is analogous to a large laboratory. Thanks to diverse high-tech clusters in the technological area, the country has enabled collaboration with industry leaders, innovation drivers, and capital providers. Tight links between business, academics, and venture funds are particularly beneficial for translating research, testing new applications, and advancing inventions. As such, the country is particularly ideal for technological startups looking to access capital to advance, commercialize, and grow their research into sustainable businesses.













Comments


bottom of page